Repligen Corporation (RGEN)
USD 143.07
(-6.37%)
USD 143.07
(-6.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -39.51 Million USD | 60.68% |
| 2022 | -100.49 Million USD | 57.73% |
| 2021 | -237.76 Million USD | 46.19% |
| 2020 | -441.87 Million USD | -66.7% |
| 2019 | -265.07 Million USD | -193.44% |
| 2018 | -90.33 Million USD | -21.24% |
| 2017 | -74.5 Million USD | -60.21% |
| 2016 | -46.5 Million USD | 36.64% |
| 2015 | -73.4 Million USD | -18.39% |
| 2014 | -62 Million USD | -55.67% |
| 2013 | -39.82 Million USD | -36.36% |
| 2012 | -29.2 Million USD | -105.65% |
| 2011 | -14.2 Million USD | -13.39% |
| 2010 | -12.52 Million USD | -148.46% |
| 2009 | -5.04 Million USD | 84.52% |
| 2008 | -32.56 Million USD | -321.43% |
| 2007 | -7.72 Million USD | -42.33% |
| 2006 | -5.42 Million USD | -75.29% |
| 2005 | -3.09 Million USD | 21.77% |
| 2004 | -3.95 Million USD | 35.19% |
| 2003 | -6.1 Million USD | 29.76% |
| 2002 | -8.69 Million USD | 46.2% |
| 2001 | -16.16 Million USD | 35.93% |
| 2000 | -25.22 Million USD | -664.44% |
| 1999 | -3.3 Million USD | 29.79% |
| 1998 | -4.7 Million USD | -34.29% |
| 1997 | -3.5 Million USD | 49.28% |
| 1996 | -6.9 Million USD | 25.0% |
| 1995 | -9.2 Million USD | 60.17% |
| 1994 | -23.1 Million USD | 11.15% |
| 1993 | -26 Million USD | 9.41% |
| 1992 | -28.7 Million USD | -26.99% |
| 1991 | -22.6 Million USD | -29.89% |
| 1990 | -17.4 Million USD | -104.71% |
| 1989 | -8.5 Million USD | -2.41% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -42.88 Million USD | -8.52% |
| 2024 Q2 | -66.29 Million USD | -54.58% |
| 2023 Q3 | -210.89 Million USD | -16.64% |
| 2023 Q1 | -95.91 Million USD | 4.56% |
| 2023 Q2 | -180.8 Million USD | -88.51% |
| 2023 FY | -39.51 Million USD | 60.68% |
| 2023 Q4 | -39.51 Million USD | 81.26% |
| 2022 Q4 | -100.49 Million USD | 35.1% |
| 2022 Q3 | -154.85 Million USD | 13.89% |
| 2022 Q1 | -191.05 Million USD | 19.64% |
| 2022 FY | -100.49 Million USD | 57.73% |
| 2022 Q2 | -179.83 Million USD | 5.87% |
| 2021 FY | -237.76 Million USD | 46.19% |
| 2021 Q1 | -431.42 Million USD | 2.36% |
| 2021 Q2 | -428.33 Million USD | 0.72% |
| 2021 Q3 | -307.33 Million USD | 28.25% |
| 2021 Q4 | -237.76 Million USD | 22.64% |
| 2020 Q3 | -281.52 Million USD | 3.57% |
| 2020 Q2 | -291.94 Million USD | -10.89% |
| 2020 Q1 | -263.28 Million USD | 0.68% |
| 2020 FY | -441.87 Million USD | -66.7% |
| 2020 Q4 | -441.87 Million USD | -56.96% |
| 2019 FY | -265.07 Million USD | -193.44% |
| 2019 Q4 | -265.07 Million USD | -4.29% |
| 2019 Q2 | -79.68 Million USD | -11.68% |
| 2019 Q1 | -71.35 Million USD | 21.01% |
| 2019 Q3 | -254.17 Million USD | -218.96% |
| 2018 Q3 | -87.9 Million USD | -18.34% |
| 2018 Q1 | -73.6 Million USD | 1.22% |
| 2018 FY | -90.33 Million USD | -21.24% |
| 2018 Q4 | -90.33 Million USD | -2.76% |
| 2018 Q2 | -74.28 Million USD | -0.93% |
| 2017 Q2 | -44.97 Million USD | -34.58% |
| 2017 Q1 | -33.42 Million USD | 28.14% |
| 2017 Q4 | -74.5 Million USD | -21.28% |
| 2017 FY | -74.5 Million USD | -60.21% |
| 2017 Q3 | -61.43 Million USD | -36.59% |
| 2016 Q3 | -63.33 Million USD | 20.08% |
| 2016 FY | -46.5 Million USD | 36.64% |
| 2016 Q4 | -46.5 Million USD | 26.57% |
| 2016 Q2 | -79.24 Million USD | -48.91% |
| 2016 Q1 | -53.21 Million USD | 27.51% |
| 2015 Q4 | -73.4 Million USD | -52.66% |
| 2015 Q1 | -56.28 Million USD | 9.23% |
| 2015 Q3 | -48.08 Million USD | -20.17% |
| 2015 Q2 | -40.01 Million USD | 28.91% |
| 2015 FY | -73.4 Million USD | -18.39% |
| 2014 Q4 | -62 Million USD | -72.68% |
| 2014 Q3 | -35.9 Million USD | -6.37% |
| 2014 FY | -62 Million USD | -55.67% |
| 2014 Q1 | -49.2 Million USD | -23.55% |
| 2014 Q2 | -33.75 Million USD | 31.4% |
| 2013 Q1 | -28.57 Million USD | 2.19% |
| 2013 FY | -39.82 Million USD | -36.36% |
| 2013 Q2 | -37.33 Million USD | -30.67% |
| 2013 Q3 | -42.24 Million USD | -13.16% |
| 2013 Q4 | -39.82 Million USD | 5.72% |
| 2012 Q1 | -12.79 Million USD | 0.0% |
| 2012 Q2 | -15.88 Million USD | -24.13% |
| 2012 Q3 | -18.38 Million USD | -15.81% |
| 2012 Q4 | -29.2 Million USD | -58.84% |
| 2012 FY | -29.2 Million USD | -105.65% |
| 2011 Q1 | -14.2 Million USD | -45.02% |
| 2011 Q2 | -7.46 Million USD | 47.43% |
| 2011 Q3 | -10.5 Million USD | -40.63% |
| 2011 FY | -14.2 Million USD | -13.39% |
| 2010 Q1 | -12.52 Million USD | -135.5% |
| 2010 FY | -12.52 Million USD | -148.46% |
| 2010 Q4 | -9.79 Million USD | 35.41% |
| 2010 Q3 | -15.16 Million USD | -81.97% |
| 2010 Q2 | -8.33 Million USD | 33.47% |
| 2009 Q4 | -5.31 Million USD | 24.93% |
| 2009 FY | -5.04 Million USD | 84.52% |
| 2009 Q1 | -5.04 Million USD | 66.36% |
| 2009 Q2 | -3.67 Million USD | 27.19% |
| 2009 Q3 | -7.08 Million USD | -93.03% |
| 2008 Q2 | -33.45 Million USD | -2.75% |
| 2008 FY | -32.56 Million USD | -321.43% |
| 2008 Q1 | -32.56 Million USD | -104.53% |
| 2008 Q3 | -27.12 Million USD | 18.94% |
| 2008 Q4 | -14.98 Million USD | 44.74% |
| 2007 FY | -7.72 Million USD | -42.33% |
| 2007 Q1 | -7.72 Million USD | -46.11% |
| 2007 Q2 | -6.77 Million USD | 12.29% |
| 2007 Q4 | -15.92 Million USD | 58.56% |
| 2007 Q3 | -38.41 Million USD | -466.86% |
| 2006 Q2 | -5.34 Million USD | 1.62% |
| 2006 Q4 | -5.28 Million USD | 3.49% |
| 2006 Q1 | -5.42 Million USD | -22.09% |
| 2006 FY | -5.42 Million USD | -75.29% |
| 2006 Q3 | -5.47 Million USD | -2.59% |
| 2005 Q2 | -4.72 Million USD | -52.63% |
| 2005 FY | -3.09 Million USD | 21.77% |
| 2005 Q1 | -3.09 Million USD | 6.83% |
| 2005 Q4 | -4.44 Million USD | 21.33% |
| 2005 Q3 | -5.65 Million USD | -19.58% |
| 2004 Q2 | -4.1 Million USD | -3.64% |
| 2004 Q3 | -3.95 Million USD | 3.66% |
| 2004 Q4 | -3.32 Million USD | 15.91% |
| 2004 FY | -3.95 Million USD | 35.19% |
| 2004 Q1 | -3.95 Million USD | -67.05% |
| 2003 Q4 | -2.36 Million USD | 29.59% |
| 2003 Q3 | -3.36 Million USD | 77.93% |
| 2003 FY | -6.1 Million USD | 29.76% |
| 2003 Q1 | -6.1 Million USD | -1.37% |
| 2003 Q2 | -15.24 Million USD | -149.66% |
| 2002 Q4 | -6.02 Million USD | 37.78% |
| 2002 Q3 | -9.68 Million USD | -10.61% |
| 2002 Q2 | -8.75 Million USD | -0.68% |
| 2002 Q1 | -8.69 Million USD | -52.35% |
| 2002 FY | -8.69 Million USD | 46.2% |
| 2001 Q4 | -5.7 Million USD | -60.27% |
| 2001 Q3 | -3.56 Million USD | 70.54% |
| 2001 Q2 | -12.08 Million USD | 25.21% |
| 2001 Q1 | -16.16 Million USD | -27.89% |
| 2001 FY | -16.16 Million USD | 35.93% |
| 2000 Q3 | -27.37 Million USD | -5.22% |
| 2000 FY | -25.22 Million USD | -664.44% |
| 2000 Q2 | -26.01 Million USD | -3.12% |
| 2000 Q4 | -12.63 Million USD | 53.83% |
| 2000 Q1 | -25.22 Million USD | -171.25% |
| 1999 Q4 | -9.3 Million USD | 14.68% |
| 1999 Q2 | -11.8 Million USD | -257.58% |
| 1999 Q1 | -3.3 Million USD | 10.81% |
| 1999 FY | -3.3 Million USD | 29.79% |
| 1999 Q3 | -10.9 Million USD | 7.63% |
| 1998 FY | -4.7 Million USD | -34.29% |
| 1998 Q1 | -4.7 Million USD | 4.08% |
| 1998 Q2 | -4.3 Million USD | 8.51% |
| 1998 Q3 | -4.1 Million USD | 4.65% |
| 1998 Q4 | -3.7 Million USD | 9.76% |
| 1997 Q1 | -3.5 Million USD | -6.06% |
| 1997 Q4 | -4.9 Million USD | -58.06% |
| 1997 Q3 | -3.1 Million USD | 11.43% |
| 1997 Q2 | -3.5 Million USD | 0.0% |
| 1997 FY | -3.5 Million USD | 49.28% |
| 1996 FY | -6.9 Million USD | 25.0% |
| 1996 Q2 | -3.1 Million USD | 55.07% |
| 1996 Q3 | -3.3 Million USD | -6.45% |
| 1996 Q4 | -3.3 Million USD | 0.0% |
| 1996 Q1 | -6.9 Million USD | 20.69% |
| 1995 Q1 | -9.2 Million USD | 31.34% |
| 1995 Q2 | -7.6 Million USD | 17.39% |
| 1995 Q4 | -8.7 Million USD | 23.68% |
| 1995 Q3 | -11.4 Million USD | -50.0% |
| 1995 FY | -9.2 Million USD | 60.17% |
| 1994 FY | -23.1 Million USD | 11.15% |
| 1994 Q3 | -16.7 Million USD | 32.66% |
| 1994 Q4 | -13.4 Million USD | 19.76% |
| 1994 Q1 | -23.1 Million USD | -124.27% |
| 1994 Q2 | -24.8 Million USD | -7.36% |
| 1993 Q1 | -26 Million USD | 11.56% |
| 1993 Q2 | -21 Million USD | 19.23% |
| 1993 Q3 | -17.4 Million USD | 17.14% |
| 1993 FY | -26 Million USD | 9.41% |
| 1993 Q4 | -10.3 Million USD | 40.8% |
| 1992 Q3 | -29.2 Million USD | 3.63% |
| 1992 FY | -28.7 Million USD | -26.99% |
| 1992 Q4 | -29.4 Million USD | -0.68% |
| 1992 Q1 | -28.7 Million USD | 28.78% |
| 1992 Q2 | -30.3 Million USD | -5.57% |
| 1991 Q1 | -22.6 Million USD | -6.1% |
| 1991 FY | -22.6 Million USD | -29.89% |
| 1991 Q2 | -45.2 Million USD | -100.0% |
| 1991 Q3 | -43.5 Million USD | 3.76% |
| 1991 Q4 | -40.3 Million USD | 7.36% |
| 1990 FY | -17.4 Million USD | -104.71% |
| 1990 Q1 | -17.4 Million USD | 0.0% |
| 1990 Q2 | -24.6 Million USD | -41.38% |
| 1990 Q4 | -21.3 Million USD | -3.9% |
| 1990 Q3 | -20.5 Million USD | 16.67% |
| 1989 Q1 | -8.5 Million USD | 0.0% |
| 1989 FY | -8.5 Million USD | -2.41% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 1631.151% |
| AngioDynamics, Inc. | -70.14 Million USD | 43.659% |
| AtriCure, Inc. | -9.81 Million USD | -302.598% |
| Avinger, Inc. | 10.12 Million USD | 490.504% |
| Azenta, Inc. | -618.47 Million USD | 93.61% |
| BioLife Solutions, Inc. | 7.25 Million USD | 644.864% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 101.614% |
| Daxor Corporation | 755.65 Thousand USD | 5329.74% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -2588.367% |
| Femasys Inc. | -15.01 Million USD | -163.193% |
| GlucoTrack, Inc. | -4.29 Million USD | -819.902% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 202.673% |
| Hologic, Inc. | 374.4 Million USD | 110.555% |
| ICU Medical, Inc. | 1.45 Billion USD | 102.725% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 98.514% |
| KORU Medical Systems, Inc. | -7.03 Million USD | -461.579% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -663.8% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -821.737% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -821.737% |
| Masimo Corporation | 804 Million USD | 104.915% |
| Microbot Medical Inc. | -2.28 Million USD | -1628.74% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | -311.839% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 113.076% |
| Nephros, Inc. | -2.47 Million USD | -1499.312% |
| NovoCure Limited | 355.42 Million USD | 111.119% |
| NEXGEL, Inc. | 98 Thousand USD | 40425.51% |
| NEXGEL, Inc. | 98 Thousand USD | 40425.51% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 166.919% |
| OraSure Technologies, Inc. | -276.9 Million USD | 85.728% |
| Pro-Dex, Inc. | 10.91 Million USD | 462.028% |
| Pulse Biosciences, Inc. | -35.22 Million USD | -12.203% |
| Predictive Oncology Inc. | -5.87 Million USD | -573.025% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 1404.609% |
| QuidelOrtho Corporation | 2.49 Billion USD | 101.584% |
| Sanara MedTech Inc. | 6.64 Million USD | 694.727% |
| STAAR Surgical Company | -147.2 Million USD | 73.154% |
| Sharps Technology, Inc. | -3.01 Million USD | -1211.656% |
| Utah Medical Products, Inc. | -92.52 Million USD | 57.289% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 102.011% |
| Jin Medical International Ltd. | -2.81 Million USD | -1303.12% |